Vargas CDA

Language: Spanish
References: 10
Page: 105-108
PDF size: 171.31 Kb.

ABSTRACT

Oral Mucositis is a key symptom, being the most common complication in patients undergoing chemotherapy. It is important in clinical practice to be able to prevent and if so, care for, with adequate nutritional support. If left untreated, these harmful lesions could compromise the patient, from severe dehydration to sepsis and possible death.

REFERENCES

1. Adelberg, D. E., & Bishop, M. R. (2009). Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation. Emergency medicine clinics of North America, 27(2), pagina 320

2. DeVita V., Lawrence T., & Rosenberg S., (2011). CANCER PRINCIPLES & PRACTICE OF ONCOLOGY (10ma. Ed.) United States of America; Wolters Kluwer Health, pagina 2888-2901.

3. Gamarra Aguirre, J. A. (2011). Frecuencia de mucositis oral post quimioterapia con esquema folfox IV en pacientes con cáncer gástrico. Servicio de medicina oncológica. Hospital Víctor Lazarte Echegaray, Abril-Julio, Trujillo 2011.

4. Goyri, B. L. M., Ramos, M. E. C., & Echevarría, E. (2014). Estomatotoxicidad bucal inducida por quimioterapia. Revista odontológica mexicana, 18(2), 89- 95.

5. Keefe, D. M., Schubert, M. M., Elting, L. S., Sonis, S. T., Epstein, J. B., Raber-Durlacher, J. E., ... & Peterson, D. E. (2007). Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer, 109(5), 820-831.

6. Lancheros-Páez, L. L., Merchán- Chaverra, R. A., & Martínez-Anaya, L. J. (2014). Tamización del riesgo nutricional en el paciente oncológico. Rev Fac Med, 62(Supl 1), S57-64.

7. Lalla, R. V., Bowen, J., Barasch, A., Elting, L., Epstein, J., Keefe, D. M., ... & Elad, S. (2014). MASCC/ISOO clinical practice guidelines for the management of mucositis secundary to cancer therapy. Cancer, 120(10), 1453-1461.

8. McGuire, D. B., Fulton, J. S., Park, J., Brown, C. G., Correa, M. E. P., Eilers, J., ... & Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO. (2013). Systematic review of basic oral care for the management of oral mucositis in cancer patients. Supportive Care in Cancer, 21(11), 3165-3177.

9. Poletti-Vázquez, E. D. (2014). Estomatitis por metotrexato y sus efectos orales a bajas dosis. Dermatol Rev Mex, 58, 458-464.

10. Rubenstein, E. B., Peterson, D. E., Schubert, M., Keefe, D., McGuire, D., Epstein, J., ... & Sonis, S. T. (2004). Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis. Cancer, 100(S9), 2026-2046.